Glenmark Pharma has received final USFDA approval for anti-fungal ointment nystatin and triamcinolone acetonide.The company also received tentative approval for Olmesartan medoxomil, used for the […]
Alembic Pharmaceuticals Ltd has received final USFDA approval for its Lacosamide tablets, which is indicated as adjunctive therapy in patients with partial onset seizures. The […]
Claris Lifesciences has received USFDA approval for generic Tobramycin injection used for the treatment of bacterial infections. The estimated market size of the product in […]
Aurobindo Pharma has received final approval from the USFDA to manufacture and market Fenofibrate tablets which are used for the treatment of high level of […]
Sun Pharmaceutical Industries has received final USFDA approval for its non-steroid drug BromSite used to treat inflammation and prevent pain in patients undergoing cataract surgery. […]
Dr. Reddys Laboratories has signed up Cutis Pharma of USA for active pharmaceutical ingredient (API) supply and joint development agreements. The company will engage in […]
Glenmark Pharmaceuticals has received USFDA final approval for bendamustine hydrochloride for injection, 25 mg/vial and 100 mg/vial, the therapeutic equivalent to the reference listed drug […]
Aurobindo Pharma has received final USFDA to manufacture and market Rivastigmine Tartrate Capsules USP which is used for the treatment of dementia disease, in the […]
Aurobindo Pharma has received final USFDA approval to manufacture and market pantoprazole sodium for injections, used for the treatment of gastroesophageal reflux disease, in the […]
Nesher Pharmaceuticals, an arm of Zydus Pharmaceuticals USA has received its first Abbreviated New Drug Application (ANDA) approval from the US FDA to market Dextroamphetamine […]
Copyright © 2026 | WordPress Theme by MH Themes